ReviewDer Urologe. Ausg. A2020

[Why have tyrosine kinase inhibitors failed in the adjuvant situation and do checkpoint inhibitors make more sense?]

Susanne KregePubMed ↗Publisher ↗

No numbers read from the abstract.